Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05784753 · ClinicalTrials.gov registry record · NA

HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction

A NA study of HFpEF - Heart Failure With Preserved Ejection Fraction, sponsored by University of Nebraska.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
3
Study locations

NCT05784753: Recruiting NA study of HFpEF - Heart Failure With Preserved Ejection Fraction, sponsored by University of Nebraska.

NCT05784753 is a NA study of HFpEF - Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 300 participants, below the 9,831-participant average among 6 other HFpEF - Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05784753, a NA study of HFpEF - Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by University of Nebraska.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
3
Study locations

Study Summary

The goal of this study is to learn more about patients with heart failure with preserved ejection fraction (HFpEF) and exercise. Investigators want to see if meeting with a coach in person or by video conference will help these patients exercise, feel better, and change markers in their blood. Participants will be randomly placed in one of three groups for 18 months. All groups will have access to a fitness center and be given a watch and heart rate monitor to wear during exercise. The usual care group (control group) will have access to exercise videos via the medical fitness center and will not meet with a coach. The HEART Camp group will exercise and meet with their coach in-person at the medical fitness center. The HEART Camp Connect group will have access to exercise videos via the medical fitness center and will meet with their coach via videoconferencing. All participants will take part in an exercise test and study training prior to being randomized. At four data collection time points, participants will wear an activity monitor for 7 days each, have their blood drawn, and answer questions related to heart failure and exercise. Participants will also wear a heart rate monitor when they exercise and fill out a daily exercise diary.

Primary Outcome

Adherence is measured as weekly minutes of moderate intensity exercise as measured by a watch and heart rate sensor.

Conditions Studied

HFpEF - Heart Failure With Preserved Ejection Fraction

Interventions

  • BEHAVIORAL HEART Camp
  • BEHAVIORAL HEART Camp Connect

Study Locations (3)

Michigan

  • Henry Ford Health System - Detroit

Nebraska

  • University of Nebraska Medical Center - Omaha

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-11-20
Est. Completion 2028-03
Phase NA
University of Nebraska

407 total trials

What NCT05784753 shows while recruiting

NCT05784753 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 9,831-participant average among 6 other HFpEF - Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (97% lower).

The record links to 1 condition, with HFpEF - Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 2 interventions - of which HEART Camp is the first listed.

NCT05784753 reports a single indexed study location in Michigan, Nebraska, Virginia.

Frequently Asked Questions

What is clinical trial NCT05784753 about?

NCT05784753 is a clinical study titled "HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction". The goal of this study is to learn more about patients with heart failure with preserved ejection fraction (HFpEF) and exercise. Investigators want to see if meeting with a coach in person or by video conference will help these patients exercise, feel better, and change markers in their blood. Parti...

What is the current status of trial NCT05784753?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-11-20. Estimated completion is 2028-03.

What conditions does trial NCT05784753 study?

This clinical trial studies the following conditions: HFpEF - Heart Failure With Preserved Ejection Fraction.

What interventions are being tested in trial NCT05784753?

The interventions under investigation include: HEART Camp (BEHAVIORAL), HEART Camp Connect (BEHAVIORAL).

Who is sponsoring clinical trial NCT05784753?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05784753 being conducted?

This trial has 3 study locations across Michigan, Nebraska, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HFpEF - Heart Failure With Preserved Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05784753

Source: ClinicalTrials.gov NCT05784753, the US trial registry maintained by the National Library of Medicine. NCT05784753 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.